SecBot SecBot
Insider Cluster (7 insiders) ·Filed Nov 5, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 7h ago
Insider cluster: 7 insiders, $9.6M total
Actionable Insight • Neutral

The sales are small relative to market cap and occur after a strong earnings beat, suggesting routine portfolio diversification rather than negative signaling. Monitor next quarter's insider activity for any change in pattern, particularly if C-suite officers increase selling volume.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$904.35
T+0 close · Nov 5, 2026 · via day close
Latest settled
+5.65%
T+5 · $955.47
Vs SPY
+3.06%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $904.35entry
  2. T+1 · 8d ago +1.73%α −0.64% · $919.96
  3. T+5 · 4d ago +5.65%α +3.06% · $955.47
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Seven Regeneron insiders sold a total of $9.56M in open-market sales over the week following a strong Q3 earnings beat (revenue +36% YoY, EPS +35% YoY). The sales include two C-suite executives (EVP General Counsel and EVP Commercial) and five directors; two of the sales were under 10b5-1 plans. The total represents ~0.01% of market cap, well below the 0.1% threshold for materiality, making this a routine cluster likely driven by post-earnings window openings and personal portfolio management.

Key Financial Metrics

Direction
selling
Total Value
$9.6M
Insiders
7

Key Facts

  • Seven insiders sold $9.56M in open-market sales (code S) over a 7-day window ending Nov 4, 2026
  • Sales follow Q3 2026 earnings on Oct 30: revenue $5.116B (+36% YoY), GAAP EPS $18.45 (+35% YoY), both above consensus
  • Total sales are ~0.01% of $96.3B market cap, far below the 0.1% materiality threshold
  • Two sales (Brown, McCourt, Guarini) were under 10b5-1 plans; four were not; one (Pitofsky) is detailed separately with derivative exercises
  • No C-suite CEO or CFO sales; the most senior sellers are EVPs and directors
  • The cluster includes non-cash derivative exercises and gifts by Zoghbi, Murphy, and Pitofsky that have no economic impact

Financial Impact

Total open-market sales of $9.56M, representing ~0.01% of market cap

insider ownership

Risk Factors

  • Insider sales after a strong earnings beat could be interpreted negatively by some market participants, but the size is immaterial
  • No C-suite CEO/CFO sales reduces signaling value
  • Two sales under 10b5-1 plans indicate pre-planned trades, not reactive selling

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-REGN-1793998938623

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026